{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:10:06Z","timestamp":1789049406137,"version":"build-2803163510"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Euglycemic diabetic ketoacidosis (EuDKA) is a rare variant of diabetic ketoacidosis (DKA), characterized by normal or near-normal glucose levels despite severe metabolic acidosis and ketosis. This condition poses a diagnostic challenge as it mimics DKA without the hallmark hyperglycemia. Recent studies have suggested an association between EuDKA and newer antidiabetic medications, including dipeptidyl peptidase-4 (DPP-4) inhibitors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concern:<\/jats:title>\n            <jats:p>A 57-year-old male with a history of type 2 diabetes, hypertension, ischemic heart disease, and rheumatoid arthritis developed EuDKA following a traumatic brain injury. Despite a blood glucose of 134\u2009mg\/dL, he exhibited classic features of DKA, including severe metabolic acidosis, low bicarbonate levels, an elevated anion gap, and positive urinary ketones.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Despite the blood glucose level being within normal range, the patient\u2019s clinical presentation, including severe acidosis (pH 7.16), low bicarbonate (2.8 mmol\/L), elevated anion gap (24.9 mmol\/L), and urinary ketones, pointed to EuDKA. The patient\u2019s use of Sitagliptin, a DPP-4 inhibitor, was identified as a likely precipitating factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Timely interventions, including fluid resuscitation, insulin therapy, and electrolyte correction, were promptly administered to manage the patient\u2019s metabolic abnormalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>After receiving intensive treatment, the patient made a full recovery with normalization of metabolic parameters and no long-term complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case emphasizes the importance of maintaining a high index of suspicion for EuDKA in trauma patients, particularly those on DPP-4 inhibitors. Early recognition and prompt intervention are crucial to preventing complications and ensuring positive outcomes. Further research is needed to explore the mechanisms linking DPP-4 inhibitors with EuDKA, especially in the context of metabolic stress like traumatic brain injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043562","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T10:02:08Z","timestamp":1753956128000},"page":"e43562","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Euglycemic DKA in a DPP-4 inhibitor patient following traumatic brain injury: A complex ICU glucose management challenge"],"prefix":"10.1097","volume":"104","author":[{"given":"Isam","family":"Shammas","sequence":"first","affiliation":[{"name":"Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Seyaj","sequence":"additional","affiliation":[{"name":"Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6029-9328","authenticated-orcid":false,"given":"Kenana","family":"Altell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hebron University, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9882-3677","authenticated-orcid":false,"given":"Razan","family":"Sobeih","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hebron University, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1217-6597","authenticated-orcid":false,"given":"Lara","family":"Asafrah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hebron University, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Burqan","sequence":"additional","affiliation":[{"name":"Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoun","family":"Abuhalawa","sequence":"additional","affiliation":[{"name":"Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shahateet","sequence":"additional","affiliation":[{"name":"Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Itkaidek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Al-Ahli Hospital, Hebron, State of Palestine."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review.","volume":"13","author":"Modi","year":"2017","journal-title":"Curr Diabetes Rev"},{"key":"R2-20251014","first-page":"1","article-title":"A case of euglycemic diabetic ketoacidosis (DKA), influenza, and a dipeptidyl peptidase-4 (DPP-4) inhibitor.","volume":"15","author":"Jeong","year":"2023","journal-title":"Cureus"},{"issue":"suppl_1","key":"R3-20251014","first-page":"s94","article-title":"Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in diabetes.","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","article-title":"Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus.","volume":"16","author":"Deacon","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R5-20251014","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/metabo14050264","article-title":"Ketoacidosis and SGLT2 Inhibitors: a narrative review.","volume":"14","author":"Morace","year":"2024","journal-title":"Metabolites"},{"key":"R6-20251014","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.2337\/db14-0052","article-title":"Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors.","volume":"63","author":"Omar","year":"2014","journal-title":"Diabetes"},{"key":"R7-20251014","first-page":"1","article-title":"Treatment challenges and controversies in the management of critically Ill diabetic ketoacidosis (DKA) patients in intensive care units.","volume":"16","author":"Dunn","year":"2024","journal-title":"Cureus"},{"key":"R9-20251014","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00125-024-06183-8","article-title":"Hyperglycaemic crises in adults with diabetes: a consensus report.","volume":"67","author":"Umpierrez","year":"2024","journal-title":"Diabetologia"},{"key":"R10-20251014","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/phar.4600","article-title":"Lactated Ringer\u2019s versus normal saline in the management of acute diabetic ketoacidosis (RINSE\u2010DKA).","volume":"44","author":"Jamison","year":"2024","journal-title":"Pharmacotherapy"},{"key":"R11-20251014","first-page":"e56723","article-title":"A Re-audit of the management of diabetic ketoacidosis (DKA): the importance of the seven-day working inpatient diabetes specialist nurse service.","volume":"16","author":"Periyasami","year":"2024","journal-title":"Cureus"},{"key":"R12-20251014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","article-title":"Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.","volume":"44","author":"Long","year":"2021","journal-title":"Am J Emerg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:02:59Z","timestamp":1760461379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":11,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043562","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"2025-01-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}